Khanam, R.; Faiman, B.; Batool, S.; Najmuddin, M.M.; Usman, R.; Kuriakose, K.; Ahmed, A.; Rehman, M.E.U.; Roksana, Z.; Syed, Z.;
et al. Management of Adverse Reactions for BCMA-Directed Therapy in Relapsed Multiple Myeloma: A Focused Review. J. Clin. Med. 2023, 12, 5539.
https://doi.org/10.3390/jcm12175539
AMA Style
Khanam R, Faiman B, Batool S, Najmuddin MM, Usman R, Kuriakose K, Ahmed A, Rehman MEU, Roksana Z, Syed Z,
et al. Management of Adverse Reactions for BCMA-Directed Therapy in Relapsed Multiple Myeloma: A Focused Review. Journal of Clinical Medicine. 2023; 12(17):5539.
https://doi.org/10.3390/jcm12175539
Chicago/Turabian Style
Khanam, Razwana, Beth Faiman, Saba Batool, Mohammed Musa Najmuddin, Rana Usman, Kiran Kuriakose, Arooj Ahmed, Mohammad Ebad Ur Rehman, Zinath Roksana, Zain Syed,
and et al. 2023. "Management of Adverse Reactions for BCMA-Directed Therapy in Relapsed Multiple Myeloma: A Focused Review" Journal of Clinical Medicine 12, no. 17: 5539.
https://doi.org/10.3390/jcm12175539
APA Style
Khanam, R., Faiman, B., Batool, S., Najmuddin, M. M., Usman, R., Kuriakose, K., Ahmed, A., Rehman, M. E. U., Roksana, Z., Syed, Z., Anwer, F., & Raza, S.
(2023). Management of Adverse Reactions for BCMA-Directed Therapy in Relapsed Multiple Myeloma: A Focused Review. Journal of Clinical Medicine, 12(17), 5539.
https://doi.org/10.3390/jcm12175539